Showing 64,081 - 64,100 results of 102,577 for search '(( 5 ((c decrease) OR (a decrease)) ) OR ( 5 ((nn decrease) OR (mean decrease)) ))', query time: 2.00s Refine Results
  1. 64081

    Gas-Phase Surface Engineering of Polystyrene Beads Used to Challenge Automated Particle Inspection Systems by Vickie Labonté (2861663)

    Published 2016
    “…Following treatment, newly grafted C–OH, C–O–C, CO, and COOH functional groups on the bead’s surface are observed by X-ray photoelectron spectroscopy and Fourier transform infrared spectroscopy, leading to an increase in the surface energy from 31 ± 1 to 65 ± 2 mJ/m<sup>2</sup> and a corresponding zeta potential decrease from −38 to −61 mV. …”
  2. 64082

    Gas-Phase Surface Engineering of Polystyrene Beads Used to Challenge Automated Particle Inspection Systems by Vickie Labonté (2861663)

    Published 2016
    “…Following treatment, newly grafted C–OH, C–O–C, CO, and COOH functional groups on the bead’s surface are observed by X-ray photoelectron spectroscopy and Fourier transform infrared spectroscopy, leading to an increase in the surface energy from 31 ± 1 to 65 ± 2 mJ/m<sup>2</sup> and a corresponding zeta potential decrease from −38 to −61 mV. …”
  3. 64083
  4. 64084

    Stringency of the association of Vsp-recombinant <i>B. burgdorferi</i> clones with human brain endothelium. by Gaurav Gandhi (239145)

    Published 2010
    “…In some experiments we incubated B31-5A18NP1-Vsp1 with HBMEC also at 4°C (panel B). …”
  5. 64085

    SC-1 Inhibited RSK2 Kinase Activity <i>in vitro</i> and an RSK2 Inhibitor Increased Colony Formation. by Susan D. Mertins (380936)

    Published 2013
    “…<p>COLO 205 tumor cell line was treated with SL0101 (1.25 µM) and SC-1 (0.1 µM) for 24 hrs prior to soft agar cloning, lysate preparation, and immunoblotting. A. SC-1 inhibited RSK2 N-terminal domain <i>in vitro</i> kinase activity with an EC<sub>50</sub> of 2.5±1.8 µM (mean±SD, n = 5) but not in other like assays for Aurora kinase B, CHK1, or CHK2 kinases. …”
  6. 64086

    Table1_Role of the multi-drug efflux systems on the baseline susceptibility to ceftazidime/avibactam and ceftolozane/tazobactam in clinical isolates of non-carbapenemase-producing... by María José Contreras-Gómez (13896657)

    Published 2022
    “…Although the contribution of RND activity to CZA and C/T baseline susceptibility was generally low (two-fold decrease of minimal inhibitory concentrations [MIC]), a more evident contribution was observed in a non-minor proportion of the Non-CP-CRPA isolates affected by PAβN [CZA: 25.4% (15/59); C/T: 30% (21/70)]. …”
  7. 64087

    Table2_Role of the multi-drug efflux systems on the baseline susceptibility to ceftazidime/avibactam and ceftolozane/tazobactam in clinical isolates of non-carbapenemase-producing... by María José Contreras-Gómez (13896657)

    Published 2022
    “…Although the contribution of RND activity to CZA and C/T baseline susceptibility was generally low (two-fold decrease of minimal inhibitory concentrations [MIC]), a more evident contribution was observed in a non-minor proportion of the Non-CP-CRPA isolates affected by PAβN [CZA: 25.4% (15/59); C/T: 30% (21/70)]. …”
  8. 64088
  9. 64089
  10. 64090
  11. 64091

    Line3-2 reveals lung hypoplasia and limb syndactyly. by Carsten Schnatwinkel (48)

    Published 2012
    “…<p>(A–H) Embryos dissected at E18.5 (A) reveal that line3-2 mutants are slightly reduced in size and have significantly smaller lung lobes (B–F). …”
  12. 64092
  13. 64093

    Table_4_Prospective Study Reveals Host Microbial Determinants of Clinical Response to Fecal Microbiota Transplant Therapy in Type 2 Diabetes Patients.docx by Dafa Ding (6548732)

    Published 2022
    “…</p>Results<p>We found that the GM of T2DM patients was reconstituted by FMT. We observed a statistically significant decrease in HbA1c% (from 7.565 ± 0.148 to 7.190 ± 0.210, p<0.01), blood glucose (from 8.483 ± 0.497 to 7.286 ± 0.454 mmol/L, p<0.01), and uric acid (from 309.4 ± 21.5 to 259.1 ± 15.8 µmol/L, p<0.01) while a significant increase in postprandial C-peptide (from 4.503 ± 0.600 to 5.471 ± 0.728 ng/ml, p<0.01) at 12 weeks after FMT. …”
  14. 64094

    Table_1_Prospective Study Reveals Host Microbial Determinants of Clinical Response to Fecal Microbiota Transplant Therapy in Type 2 Diabetes Patients.xlsx by Dafa Ding (6548732)

    Published 2022
    “…</p>Results<p>We found that the GM of T2DM patients was reconstituted by FMT. We observed a statistically significant decrease in HbA1c% (from 7.565 ± 0.148 to 7.190 ± 0.210, p<0.01), blood glucose (from 8.483 ± 0.497 to 7.286 ± 0.454 mmol/L, p<0.01), and uric acid (from 309.4 ± 21.5 to 259.1 ± 15.8 µmol/L, p<0.01) while a significant increase in postprandial C-peptide (from 4.503 ± 0.600 to 5.471 ± 0.728 ng/ml, p<0.01) at 12 weeks after FMT. …”
  15. 64095

    Table_3_Prospective Study Reveals Host Microbial Determinants of Clinical Response to Fecal Microbiota Transplant Therapy in Type 2 Diabetes Patients.docx by Dafa Ding (6548732)

    Published 2022
    “…</p>Results<p>We found that the GM of T2DM patients was reconstituted by FMT. We observed a statistically significant decrease in HbA1c% (from 7.565 ± 0.148 to 7.190 ± 0.210, p<0.01), blood glucose (from 8.483 ± 0.497 to 7.286 ± 0.454 mmol/L, p<0.01), and uric acid (from 309.4 ± 21.5 to 259.1 ± 15.8 µmol/L, p<0.01) while a significant increase in postprandial C-peptide (from 4.503 ± 0.600 to 5.471 ± 0.728 ng/ml, p<0.01) at 12 weeks after FMT. …”
  16. 64096

    Image_1_Prospective Study Reveals Host Microbial Determinants of Clinical Response to Fecal Microbiota Transplant Therapy in Type 2 Diabetes Patients.pdf by Dafa Ding (6548732)

    Published 2022
    “…</p>Results<p>We found that the GM of T2DM patients was reconstituted by FMT. We observed a statistically significant decrease in HbA1c% (from 7.565 ± 0.148 to 7.190 ± 0.210, p<0.01), blood glucose (from 8.483 ± 0.497 to 7.286 ± 0.454 mmol/L, p<0.01), and uric acid (from 309.4 ± 21.5 to 259.1 ± 15.8 µmol/L, p<0.01) while a significant increase in postprandial C-peptide (from 4.503 ± 0.600 to 5.471 ± 0.728 ng/ml, p<0.01) at 12 weeks after FMT. …”
  17. 64097

    Table_2_Prospective Study Reveals Host Microbial Determinants of Clinical Response to Fecal Microbiota Transplant Therapy in Type 2 Diabetes Patients.xlsx by Dafa Ding (6548732)

    Published 2022
    “…</p>Results<p>We found that the GM of T2DM patients was reconstituted by FMT. We observed a statistically significant decrease in HbA1c% (from 7.565 ± 0.148 to 7.190 ± 0.210, p<0.01), blood glucose (from 8.483 ± 0.497 to 7.286 ± 0.454 mmol/L, p<0.01), and uric acid (from 309.4 ± 21.5 to 259.1 ± 15.8 µmol/L, p<0.01) while a significant increase in postprandial C-peptide (from 4.503 ± 0.600 to 5.471 ± 0.728 ng/ml, p<0.01) at 12 weeks after FMT. …”
  18. 64098

    Induction of apoptosis by pinostrobin in human cervical cancer cells: Possible mechanism of action by Alka Jaudan (4839792)

    Published 2018
    “…Additionally, a significant increase in the expression of proteins of extrinsic (TRAIL R1/DR4, TRAIL R2/DR5, TNF RI/TNFRSF1A, FADD, Fas/TNFRSF6) and intrinsic pathway (Bad, Bax, HTRA2/Omi, SMAC/Diablo, cytochrome C, Pro-Caspase-3, Cleaved Caspase-3) was observed in the cells exposed to P<sub>N</sub>. …”
  19. 64099

    Crop-Specific Emission Projection Suggests Peaking of Agricultural N<sub>2</sub>O by the Middle Century by Tianyuan Zhang (2501488)

    Published 2024
    “…Our findings show that global agricultural N<sub>2</sub>O emissions will peak around 2065, ranging from 5.2 to 6.6 Tg N a<sup>–1</sup>. Corn cultivation is the primary N<sub>2</sub>O contributor, while rice production will produce fewer emissions and peak before 2025. …”
  20. 64100

    Presentation_1_Rhizobacteria From Root Nodules of an Indigenous Legume Enhance Salinity Stress Tolerance in Soybean.pdf by Gayathri Ilangumaran (10039691)

    Published 2021
    “…<p>Soybean is the most widely grown legume worldwide, but it is a glycophyte and salinity stress can decrease its yield potential up to 50%. …”